Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry

M Guger; Christian Enzinger; F Leutmezer; J Kraus; T Berger

Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry

M Guger
, Christian Enzinger
, F Leutmezer
, J Kraus
, T Berger

Universitätsklinik für Neurologie

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

Originalsprache	Englisch
Fachzeitschrift	Multiple Sclerosis Journal
Publikationsstatus	Veröffentlicht - 2015
Veranstaltung	31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis - Barcelona, Spanien Dauer: 7 Okt. 2015 → 10 Okt. 2015

Wissenschaftszweige

302 Klinische Medizin
305 Andere Humanmedizin, Gesundheitswissenschaften

Andere Dateien und Links

Web of Science

Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry
Guger, M. (Autor*in), Enzinger, C. (Autor*in), Leutmezer, F. (Autor*in), Kraus, J. (Autor*in) & Berger, T. (Autor*in)
2015
Aktivität: Vortrag oder Poster › Poster

Dieses zitieren

@article{e5ea1529c3e04a0486a3b82cb64e6702,

title = "Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry",

author = "M Guger and Christian Enzinger and F Leutmezer and J Kraus and T Berger",

year = "2015",

language = "English",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

note = "31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS 31 ; Conference date: 07-10-2015 Through 10-10-2015",

}

TY - JOUR

T1 - Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry

AU - Guger, M

AU - Enzinger, Christian

AU - Leutmezer, F

AU - Kraus, J

AU - Berger, T

PY - 2015

Y1 - 2015

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000365729400483

M3 - Conference abstract

SN - 1352-4585

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

T2 - 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis

Y2 - 7 October 2015 through 10 October 2015

ER -

Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry

Wissenschaftszweige

Andere Dateien und Links

Aktivitäten

Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry

Dieses zitieren